Pliant Therapeutics (PLRX) Other Gross PP&E Adjustments (2019 - 2026)

Pliant Therapeutics (PLRX) has 8 years of Other Gross PP&E Adjustments data on file, last reported at -$10.0 million in Q1 2026.

• Other Gross PP&E Adjustments for Q1 2026 came in at -$10.0 million, down 0.94% year-over-year; the trailing twelve-month figure through Mar 2026 was -$10.0 million (down 0.94% YoY), and the FY2025 annual result was -$17.1 million, up 8.01% from the prior year.
• Other Gross PP&E Adjustments improved to -$10.0 million in Q1 2026 per PLRX's latest filing, from -$17.1 million in the prior quarter.
• Over five years, Other Gross PP&E Adjustments peaked at $10.4 million in Q3 2023 and troughed at -$18.6 million in Q4 2024.
• A 5-year average of -$2.5 million and a median of $832000.0 in 2022 frame the typical range for Other Gross PP&E Adjustments.
• The sharpest annual moves came in 2023 and 2024: Other Gross PP&E Adjustments jumped 230.17% in 2023, then tumbled 778.3% in 2024.
• A 5-year view of Other Gross PP&E Adjustments shows it stood at $832000.0 in 2022, then jumped by 230.17% to $2.7 million in 2023, then plunged by 778.3% to -$18.6 million in 2024, then increased by 8.01% to -$17.1 million in 2025, then jumped by 41.49% to -$10.0 million in 2026.
• Business Quant data shows PLRX's Other Gross PP&E Adjustments at -$10.0 million in Q1 2026, -$17.1 million in Q4 2025, and -$8.4 million in Q3 2025.